Great-grandfather who bravely lost half his face to rare cancer is given the devastating news the disease is now incurable
Raymond Martin, 64, from Newcastle, has facial angiosarcoma, a rare form of cancer that has caused a gaping hole to develop under his right eye. Doctors say no treatment can now help him. (Source: the Mail online | Health)
Source: the Mail online | Health - March 24, 2015 Category: Consumer Health News Source Type: news
Adding Bevacizumab Ineffective in AngiosarcomaAdding Bevacizumab Ineffective in Angiosarcoma
Bevacizumab plus weekly paclitaxel did not improve outcomes in advanced angiosarcoma. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 16, 2014 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
'I've had half my face removed to save my life': Grandfather, 63, is battling rare cancer
Raymond Martin, 63, from Scotswood, Newcastle, has facial angiosarcoma, a cancer of the inner lining of blood vessels. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2013 Category: Consumer Health News Source Type: news
Angiosarcomas: Gaining a Wider Margin of SuccessAngiosarcomas: Gaining a Wider Margin of Success
Dr. Sandra D'Angelo discusses how emerging data are affecting management decisions for patients with angiosarcomas. Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 22, 2013 Category: Consumer Health News Tags: Hematology-Oncology Expert Interview Source Type: news
Angiosarcoma of the Breast
Angiosarcoma of the breast is a rarely diagnosed type of breast cancer. It can grow and spread quickly, and may affect many organs in your body. Learn the symptoms, tests to diagnose, and treatments for angiosarcoma of the breast. (Source: About.com Breast Cancer)
Source: About.com Breast Cancer - August 2, 2013 Category: Cancer & Oncology Authors: breastcancer.guide at about.com Tags: health Source Type: news
Tumor Growth In Breast Cancer And Angiosarcoma Inhibited By Novel Monoclonal Antibody
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma. In a paper published in the journal Molecular Cancer Therapeutics, a team led by Nancy Klauber-DeMore, MD, professor of surgery and a member of UNC Lineberger Comprehensive Cancer Center, used a monoclonal antibody to target SFRP2 expressed in cells from triple-negative breast cancer and the aggressive blood-vessel malignancy angiosarcoma, reducing the rate of tumor growth... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 23, 2013 Category: Consumer Health News Tags: Breast Cancer Source Type: news
Novel monoclonal antibody inhibits tumor growth in breast cancer and angiosarcoma
(University of North Carolina Health Care) A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2013 Category: Global & Universal Source Type: news
